Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors

Anna Falanga, Marina Marchetti, Daniela Massi, Barbara Merelli, Cristina Verzeroli, Laura Russo, Eliana Rulli, Carlo Tondini, Lorenzo Legramandi, Romina Nassini, Cristian Scatena, Francesco De Logu, Laura Cattaneo, Mario Mandalà

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1254-1256
Number of pages3
JournalJournal of the American Academy of Dermatology
Volume74
Issue number6
DOIs
Publication statusPublished - Jun 1 2016

ASJC Scopus subject areas

  • Dermatology

Cite this